Skip to main content

Table 1 Macrophage activation syndrome in neonatal lupus erythematosus - description of four cases in the literature

From: Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature

Sex

Antibodies

Clinical signs

Maximum Ferritin

Ng/ml

Aminotransferases IU/L

Hematology

Triglycerides

Interleukins

Genetics

Therapy

Outcome

Reference

M

Anti Ro/SSA Anti La/SSB

22 h after birth: Complete AV-block

Cardiopulmonary resuscitation

9769 (32 h)

ASAT 1027

ALAT 121

LDH 3490

Trombopenia day 24 (90 × 10^3)

-

Sol IL-23230 U/ml

HLH-genes negative

Hydrocortisone

Relapse day 24th

Hydrocortisone till 3 months

Severe psychomotor retardation

Suzuki (2013) [3]

M

Anti Ro/SSA

Anti La/SSB

Directly after birth: Skin: annular plaques

660

ASAT 257

LDH 633

Trombopenia (104 × 10^3)

 

Sol IL-22280 U/ml

 

Prednisolone 1 mg/kg day 8 till 6 months

Good

Shimozawa (2015) [4]

F

ANA

Anti Ro/SSA

10 days after birth: Tachypnoea, Fever

Hepatosplenomegaly

Maximum 2891

Maximum day 10

ASAT 459

ALAT 463

Anemia (12.8 mg/dl)

Trombopenia lowest 12 (day 18)

Day 10: 280 mg/dL

  

IVIGS (1 g/kg 2 days)

Methylprednisolone pulse (HLH protocol 2004) Relapse day 26: Ciclosporin 6 mg/kg. 54 day’s steroids

2 months: good

Park (2015) [5]

F

ANA

Anti ENA

Anti Ro/ SSA

Anti SSB/La

Fever

Skin lesions (annular plaques)

Maximum 4439

Maximum

ASAT 84

ALAT 33

LDH 909

Day 5

Trombocytes 135

Hb lowest 7.1 mmol/L day 32

3.88 mmol/L

Sol IL-221803 pg/ml

HLH-genes negative

Prednisolone 1 mg/kg`

Tapered down in 6 months

Good

Antibodies negative after 6 months

2020

(our case)